|Bid||0.00 x N/A|
|Ask||0.00 x N/A|
|Day's range||103.55 - 105.44|
|52-week range||93.36 - 141.72|
|Beta (5Y monthly)||0.69|
|PE ratio (TTM)||23.79|
|Earnings date||24 Jan 2023 - 30 Jan 2023|
|Forward dividend & yield||1.88 (1.80%)|
|Ex-dividend date||13 Oct 2022|
|1y target est||N/A|
If you want to know who really controls Abbott Laboratories ( NYSE:ABT ), then you'll have to look at the makeup of its...
Zacks.com users have recently been watching Abbott (ABT) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
With a price-to-earnings (or "P/E") ratio of 23.7x Abbott Laboratories ( NYSE:ABT ) may be sending very bearish signals...